Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1008817
PubMed Identifier: 32970782
Publication URI: http://europepmc.org/abstract/MED/32970782
Type: Journal Article/Review
Parent Publication: PLOS Pathogens
Issue: 9
ISSN: 1553-7366